On April 16, 2025, BioGeometry officially released GeoFlow V2, the world’s first unified atomic diffusion protein foundation model for all key applications.
BioGeometry, in collaboration with Jianwei Zhu’s team from Shanghai Jiao Tong University’s School of Pharmacy, achieved a remarkable increase in the neutralizing activity of the 8G3 antibody against the latest JN.1 virus variant, boosting it by 1000-1500 times in a short period.
BioGeometry’s generative AI model, GeoFlow, redesigns the hydrophobic regions of transmembrane proteins to be soluble in water while retaining their structure and function.
BioGeometry was honored with the “Computing Power Star” award for its breakthrough in denovo protein design using generative AI and geometric deep learning.
This strategic partnership will leverage the strengths of both companies to advance innovative vaccine development and production, creating cutting-edge vaccines in China and contributing to global health.
BioGeometry and collaborators published a paper in Nature Communications, introducing the pre-trained geometric graph neural network GearBind and its application in antibody affinity maturation.
Learn MoreBioGeometry’s AI-Driven Method for Affinity Maturation Published in Nature Communications
中文